(Q51371234)

4 April 2018

title

Efficacy of Infliximab for Early Remission Induction in Refractory Uveoretinitis Associated with Behçet Disease: A 2-year Follow-up Study. (English)

1 reference

4 April 2018

0 references

Hiroshi Keino

1

1 reference

4 April 2018

Annabelle A Okada

2

1 reference

4 April 2018

Takayo Watanabe

3

1 reference

4 April 2018

Makiko Nakayama

4

1 reference

4 April 2018

Tomoko Nakamura

5

1 reference

4 April 2018

publication date

21 October 2016

1 reference

4 April 2018

Ocular Immunology and Inflammation

published in

1 reference

4 April 2018

volume

25

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

46-51

1 reference

4 April 2018

Current concepts in the etiology and treatment of Behçet disease

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

A Major Review: Current Aspects of Ocular Behçet's Disease in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Ocular immunopathology of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273948.2016.1239746

10.1080/09273948.2016.1239746

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

27767359

1 reference

4 April 2018